Announcement of Change of the Company's CEO (President/General Manager)
· Issued by TaiMed Biologics Inc.
Close
Today's Information
Provided by: TaiMed Biologics Inc.
SEQ_NO
1
Date of announcement
2022/04/11
Time of announcement
15:00:23
Subject
Announcement of Change of the Company's CEO
(President/General Manager)
Date of events
2022/04/11
To which item it meets
paragraph 6
Statement
1.Date of the board of directors resolution or date of occurrence of the
change:2022/04/11
2.Position (Please enter chairperson or president/general manager):
President/General Manager
3.Name of the previous position holder:James N Chang
4.Resume of the previous position holder:
Chairperson & CEO/President of TaiMed Biologics Inc.
5.Name of the new position holder:Jimmy Chang
6.Resume of the new position holder:
Chief Operating Officer of TaiMed Biologics Inc.
7.Circumstances of change (Please enter "resignation", "dismissal",
"term expired" , "job relocation", "severance", "retirement",
"death" or "new appointment"):job relocation
8.Reason for the change:
In consideration of his approaching the retirement age, current chairman
and CEO James Chang has decided to step down from the CEO post and will
be succeeded by Jimmy Chang, Chief Operating Officer of TaiMed. The change
has received full approval from the board of directors and will take
effect on June 1st. With the completion of its 4X2,000L bioreactor cGMP
facility, TaiMed announced late last year that, in addition to its core
drug development, it intends to enter the contract manufacturing (CDMO)
market for biologics. This new arrangement will facilitate the
development and management of that important new business venture.
9.Effective date of the new appointment:2022/06/01
10.Any other matters that need to be specified:
James Chang will continue to serve as the chairperson of the Company.
